Twenty-four pyogenic liver abscesses have been treated during a six-year period percutaneously. Percutaneous management included percutaneous drainage and fine needle aspiration under ultrasound or CT scan guidance. Percutaneous management was successful in 92% of cases, and no further treatment was required in 91% of these.
INTRODUCTION
Percutaneous management of intraabdominal abscesses using fine needle aspiration and catheter drainage has become an alternative to surgical management. Several reports have emphasized its value in the management of pyogenic liver abscesses.
Fine needle aspiration, in addition to its diagnostic value, allows specific antibiotherapy and complete evacuation of the abscess cavity, which (Figure 1 ), while 16 were treated by percutaneous drainage, which was associated to fine needle aspiration in 6 cases (Figure 2 Table 2 ).
Percutaneous management was unsuccessful in two patients. The average hospital stay was 6 weeks (range 3 weeks to 4 months), largely due to the fact that the initial cause of the abscess was treated during the same hospital stay.
RESULTS
Percutaneous management was successful in 22 out of 24 patients (92%) without complications related to this method. In two patients in our early experience, percutaneous aspiration failed under ultrasound guidance. In both cases, abscesses were relatively small (4 and 3 cm diameter) and located in the dome of the liver. One patient came to surgery, while the other recovered without further treatment under antibiotic treatment. We have not observed such difficulties since 1983. In six cases, percutaneous fine needle aspiration with complete evacuation of the abscess cavity was sufficient. In 16 cases, percutaneous drainage was required and was associated with fine needle aspiration in six. Bacteriological data are listed in Table 2 . A polymicrobic abscess content was observed in five cases (20.8%).
Blood cultures were positive in only 9 cases, whereas in 17 cases organisms were isolated from the pus obtained during the percutaneous aspiration. In twelve cases, aspiration allowed germs to be demonstrated which were not found in blood cultures. In seven cases, the pus obtained remained sterile. In all these cases, broad spectrum antibiotherapy had been started before the diagnosis was established on the grounds of persistent fever. 
DISCUSSION
Percutaneous management of pyogenic liver abscess gives a mean success rate of about 80% 1' 4-6. Gerzof, in his review of the literature, found that the overall mortality of percutaneous management was lower (3 to 4%) than with surgical procedures1. In our series of 20 surgically treated pyogenic liver abscesses between 1970 and 1980, we experienced a mortality rate of 30%7. Recent series give even better results of percutaneous management with a mortality rate between 0 and 2.5% 1'3'4'6 except for Bertel et al. who observed a 13% mortality5. This rate corresponded to patients with necrotic, superinfected hepatic tumours and concomitant carcinomatosis.
Thus most authors advocate initial percutaneous drainage combined with antibiotic treatment in the management of pyogenic liver abscesses1'2'4'6'8-12. Furthermore, several authors have reported a successful outcome after short time drainage (27-72 hours) 4 and after simple aspiration combined with germ-specific antibiotherapy which might be sufficient in some cases 13'14 Failure may be due to the high viscosity of the abscess material4'5, which may be encountered in case of superinfected hematoma or necrotic tumors. Although preoperative imaging indicated slough in several patients, this was never a cause of failure, since daily lavage seems an adequate treatment via a percutaneous drain.
In our experience, percutaneous management failed to obtain recovery in two cases which were both of biliary origin. Although both cases were successfully drained, a surgical procedure was required but could only be performed in one. This does not, in our opinion, diminish 
